• Resources
  • Blog
  • Journalists
  • Log In
  • Sign Up
  • Data Privacy
  • Send a Release
Cision PR Newswire: news distribution, targeting and monitoring home
  • News
  • Products
    • Overview
    • Distribution by PR Newswire
    • Cision Communications Cloud®
    • Cision IR
    • Sponsored Placement
    • All Products
  • Contact
    • General Inquiries
    • Request a Demo
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices

 

When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Overview
  • Distribution by PR Newswire
  • Cision Communications Cloud®
  • Cision IR
  • Sponsored Placement
  • All Products
  • General Inquiries
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR
  • Overview
  • Distribution by PR Newswire
  • Cision Communications Cloud®
  • Cision IR
  • All Products
  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR
  • General Inquiries
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR

Pricing and Reimbursement in Generics - European Austerity Measures and Healthcare Cost Containment Puts Innovation-Driven Pharma Companies under Pressure


News provided by

Reportlinker

Apr 26, 2012, 09:40 ET

Share this article

Share this article


NEW YORK, April 26, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Pricing and Reimbursement in Generics - European Austerity Measures and Healthcare Cost Containment Puts Innovation-Driven Pharma Companies under Pressure

http://www.reportlinker.com/p0845625/Pricing-and-Reimbursement-in-Generics---European-Austerity-Measures-and-Healthcare-Cost-Containment-Puts-Innovation-Driven-Pharma-Companies-under-Pressure.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Managed_care

Pricing and Reimbursement in Generics - European Austerity Measures and Healthcare Cost Containment Puts Innovation-Driven Pharma Companies under Pressure

Summary

GBI Research, the leading business intelligence provider, has released its latest research "Pricing and Reimbursement in Generics - European Austerity Measures and Healthcare Cost Containment Puts Innovation-Driven Pharma Companies under Pressure". The report provides a comprehensive overview of the healthcare expenditure, healthcare regulatory system, and pricing and reimbursement process with key data, information and analysis of pricing and reimbursement decisions, across 19 countries. The report closely scrutinizes the major changes in generic drugs-related pricing and reimbursement in the 19 countries over recent years and whose impact will be felt in the near future. It also describes the efforts taken by the governing bodies in shaping the pricing and reimbursement policies of generic drugs.

GBI Research has found that expenditure towards healthcare has shown an increasing trend in most of the countries due to rising costs, resulting in budget deficits. In order to save costs, many countries have adopted reference pricing as it helps lower drug costs. Plans to increase generic drug prescription and low-cost generic drug use are being implemented in order to tackle budget deficits. Austerity measures that include price cuts and rebate reforms have been introduced in some of the countries with a view to generate maximum savings within a given period of time. These steps are being taken to build sufficient funds for future investment purposes. In most countries the focus has shifted to generic drugs as they have been successful in bringing these countries out of crisis; the countries have reformed their pricing and reimbursement structure accordingly.

Scope

- A detailed study of the healthcare systems in the US, France, Germany, the UK, Italy and Spain, the Czech Republic, Poland, Austria, Romania, Hungary, Norway, Sweden, Finland, Denmark, Japan, Australia, China and India.

- Analysis of the pricing and reimbursement mechanisms for the countries covered in the report.

- Key trends that follow from the recent changes brought about in the pricing and reimbursement system.

- An understanding of the possible major challenges brought about by the enactment of changes in the pricing and reimbursement scenario for the countries covered in the report.

Reasons to buy

- Build an understanding of the generic drugs-related key pricing and reimbursement mechanisms for the countries covered in the report.

- Optimize your investment through identification and understanding of the changes in the generic drugs regulatory mechanisms, and pricing and reimbursement scenario for the countries covered in the report.

- Develop effective business strategies related to new drug launches through the analytical insight gained from key trends in pricing and reimbursement scene for the countries covered in the report.

- Negotiate better with government agencies to maximize reimbursement of generic drugs by understanding the mechanisms.

1 Table of Contents

1 Table of Contents 3

1.1 List of Tables 5

1.2 List of Figures 6

2 Pricing and Reimbursement in Generics - Introduction 7

2.1 GBI Research Report Guidance 8

3 Pricing and Reimbursement in Generics - The US 9

3.1 Health Insurance 10

3.1.1 Health Insurance Coverage 10

3.1.2 Health Insurance Providers 10

3.2 Major Agencies Involved 12

3.3 Structure of Regulatory System 12

3.4 Pricing of Generics in the US 12

3.4.1 340B Drug Pricing Program 14

3.5 Reimbursement of Generics in the US 15

3.5.1 Health Insurance Companies 16

3.5.2 Pharmacy Benefit Managers 16

3.5.3 Reimbursement Programs in the US 17

3.6 Case Study 20

3.6.1 Pricing and Reimbursement in Oncology 20

3.7 Key Trends 20

3.7.1 Increased Availability of Generic Drugs 20

3.7.2 Patient Protection and Affordable Care Act to Tackle Soaring Prescription Drug Prices 21

3.7.3 Significant Decrease in Average Price of Generic Drugs 23

3.7.4 Generic Drugs Rebates to be Aligned for Medicare and Medicaid 23

3.7.5 Lower FEHB Drug Costs 24

3.7.6 Medicare Part D Changes in Standard Benefit Parameters 24

3.7.7 Cost-sharing of Generic Drugs 26

3.7.8 Penalty for Anemia Drug Overuse 27

3.7.9 Generic Price War at Retail Sector 27

3.8 Major Challenges 28

3.8.1 Medicare Part B Drug Pricing Does Not Accurately Reflect Market Price 28

3.8.2 Renewal of Medicaid Drug Payment Policy 28

3.8.3 Proposed Cuts in Medicare Part B Reimbursement 28

3.8.4 New Trend in Free Trade Agreements Could Affect Healthcare Programs 29

4 Pricing and Reimbursement in Generics - The Top Five Countries of Europe 30

4.1 The UK 30

4.1.1 Pricing and Reimbursement Process 31

4.1.2 Key Trends 31

4.1.3 Major Challenges 32

4.2 France 32

4.2.1 Pricing and Reimbursement Process 33

4.2.2 Key Trends 35

4.2.3 Major Challenges 37

4.3 Germany 37

4.3.1 Pricing and Reimbursement Process 38

4.3.2 Key Trends 40

4.3.3 Major Challenges 40

4.4 Italy 41

4.4.1 Pricing and Reimbursement Process 42

4.4.2 Key Trends 42

4.4.3 Major Challenges 44

4.5 Spain 44

4.5.1 Pricing and Reimbursement Process 45

4.5.2 Key Trends 45

4.5.3 Major Challenges 47

5 Pricing and Reimbursement in Generics - Eastern Europe 48

5.1 Czech Republic 48

5.1.1 Pricing and Reimbursement Process 48

5.1.2 Key Trends 49

5.1.3 Major Challenges 50

5.2 Poland 50

5.2.1 Pricing and Reimbursement Process 51

5.2.2 Key Trends 51

5.2.3 Major Challenges 52

5.3 Austria 53

5.3.1 Pricing and Reimbursement Process 53

5.3.2 Key Trends 54

5.4 Romania 54

5.4.1 Pricing and Reimbursement Process 54

5.4.2 Key Trends 55

5.4.3 Major Challenges 56

5.4.4 Case Study 57

5.5 Hungary 57

5.5.1 Pricing and Reimbursement Process 58

5.5.2 Key Trends 59

5.5.3 Major Challenges 60

6 Pricing and Reimbursement in Generics - Scandinavia 61

6.1 Norway 61

6.1.1 Pricing and Reimbursement Process 61

6.1.2 Key Trends 64

6.2 Sweden 64

6.2.1 Pricing and Reimbursement Process 64

6.2.2 Major Challenges 66

6.3 Finland 66

6.3.1 Pricing and Reimbursement Process 67

6.4 Denmark 69

6.4.1 Pricing and Reimbursement Process 69

6.4.2 Key Trends 71

7 Pricing and Reimbursement in Generics - Asia-Pacific 72

7.1 Japan 72

7.1.1 Pricing and Reimbursement Process 72

7.1.2 Key Trends 74

7.1.3 Major Challenges 74

7.2 Australia 74

7.2.1 Pricing and Reimbursement Process 75

7.2.2 Key Trends 76

7.2.3 Major Challenges 77

7.3 China 77

7.3.1 Pricing and Reimbursement Process 79

7.3.2 Key Trends 82

7.3.3 Major Challenges 83

7.4 India 85

7.4.1 Pricing and Reimbursement Process 86

7.4.2 Key Trends 90

7.4.3 Major Challenges 90

8 Pricing and Reimbursement in Generics - Appendix 92

8.1 Market Definitions 92

8.2 Abbreviations 92

8.3 Research Methodology 96

8.3.1 The US 96

8.3.2 Top Five Countries of Europe 97

8.3.3 Eastern Europe 97

8.3.4 Scandinavia 97

8.3.5 Asia-Pacific 98

8.4 Contact Us 98

8.5 Disclaimer 98

8.6 Sources 98

1.1 List of Tables

Table 1: Pricing and Reimbursement in Generics, The US, Average Retail Coinsurance Rates, By Tier (%), 2009 16

Table 2: Pricing and Reimbursement in Generics, The US, Reimbursement Programs, 2011 17

Table 3: Pricing and Reimbursement in Generics, The US, State Discount Programs, 2011 19

Table 4: Pricing and Reimbursement in Generics, The US, Annual Price Index Change in Prescription Drugs (%), 2008-2010 21

Table 5: Pricing and Reimbursement in Generics, The US, Annual Retail Price Index Change in Generic Drugs (%), 2008-2010 23

Table 6: Pricing and Reimbursement in Generics, The US, Medicare Part D Changes in Standard Benefit Parameters ($), 2008-2012 25

Table 7: Pricing and Reimbursement in Generics, The US, Generic Drug Cost-Sharing (%), 2011-2020 26

Table 8: Pricing and Reimbursement in Generics, The UK, Healthcare Expenditure, 2009 30

Table 9: Pricing and Reimbursement in Generics, France, Healthcare Expenditure, 2009 32

Table 10: Pricing and Reimbursement in Generics, Germany, Healthcare Expenditure, 2009 37

Table 11: Pricing and Reimbursement in Generics, Italy, Healthcare Expenditure, 2009-2010 41

Table 12: Pricing and Reimbursement in Generics, Spain, Healthcare Expenditure, 2009 44

Table 13: Pricing and Reimbursement in Generics, Czech Republic, Healthcare Expenditure, 2009 48

Table 14: Pricing and Reimbursement in Generics, Poland, Healthcare Expenditure, 2009 50

Table 15: Pricing and Reimbursement in Generics, Austria, Healthcare Expenditure, 2009 53

Table 16: Pricing and Reimbursement in Generics, Austria, Box Model for Reimbursement, 2011 53

Table 17: Pricing and Reimbursement in Generics, Hungary, Healthcare Expenditure, 2009 57

Table 18: Pricing and Reimbursement in Generics, Norway, Healthcare Expenditure, 2009 61

Table 19: Pricing and Reimbursement in Generics, Norway, Reimbursement Categories of Medicines, 2011 63

Table 20: Pricing and Reimbursement in Generics, Sweden, Healthcare Expenditure, 2009 64

Table 21: Pricing and Reimbursement in Generics, Sweden, Retail Sales Price, 2011 65

Table 22: Pricing and Reimbursement in Generics, Sweden, Patient Co-payments, 2011 65

Table 23: Pricing and Reimbursement in Generics, Finland, Healthcare Expenditure, 2009-2010 66

Table 24: Pricing and Reimbursement in Generics, Denmark, Healthcare Expenditure, 2009 69

Table 25: Pricing and Reimbursement in Generics, Denmark, Reimbursement Thresholds, 2011 70

Table 26: Pricing and Reimbursement in Generics, Japan, Healthcare Expenditure, 2009 72

Table 27: Pricing and Reimbursement in Generics, Japan, Trend in Revision Rates of Reimbursement Prices, 1992-2008 73

Table 28: Pricing and Reimbursement in Generics, Australia, Healthcare Expenditure, 2009 74

Table 29: Pricing and Reimbursement in Generics, Australia, Pharmacy Mark-up Price for PBS Medicines, 2011 75

Table 30: Pricing and Reimbursement in Generics, Australia, Wholesale Mark-up Price for PBS Medicines, 2011 76

Table 31: Pricing and Reimbursement in Generics, India, Effect of Jan Aushadhi Shops on Medicines, 2011 88

1.2 List of Figures

Figure 1: Pricing and Reimbursement in Generics, The US, Other Private and Government Insurance, 2011 11

Figure 2: Pricing and Reimbursement in Generics, The US, Distribution Channel Logistics and Pricing, 2011 13

Figure 3: Pricing and Reimbursement in Generics, The US, Comparison Between Fee for Service, HMO and PPO, 2011 15

Figure 4: Pricing and Reimbursement in Generics, The US, Annual Price Index Change in Prescription Drugs (%), 2008-2010 21

Figure 5: Pricing and Reimbursement in Generics, The US, Annual Retail Price Index Change in Generic Drugs (%), 2008-2010 23

Figure 6: Pricing and Reimbursement in Generics, The US, Standard Medicare Part D Benefit, 2011-2020 24

Figure 7: Pricing and Reimbursement in Generics, The US, Generic Drug Cost-Sharing (%), 2011-2020 26

Figure 8: Pricing and Reimbursement in Generics, France, LFSS, 2011 34

Figure 9: Pricing and Reimbursement in Generics, Norway, Stepped Price System, 2011 62

Figure 10: Pricing and Reimbursement in Generics, China, Healthcare Regulatory Bodies and their Roles, 2011 78

Figure 11: Pricing and Reimbursement in Generics, India, Factors Determining the Pricing of a Drug, 2011 86

Companies mentioned

To order this report:

Managed care Industry: Pricing and Reimbursement in Generics - European Austerity Measures and Healthcare Cost Containment Puts Innovation-Driven Pharma Companies under Pressure

More  Market Research Report

Check our  Industry Analysis and Insights

__________________________

Contact Nicolas: [email protected]

US: (805)-652-2626

Intl: +1 805-652-2626

SOURCE Reportlinker

Modal title

Contact Cision

  • Cision Distribution 888-776-0942
    from 8 AM - 9 PM ET

  • Chat with an Expert
  • General Inquiries
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • Cision Communication Cloud®
  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • For Small Business
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • COVID-19 Resources
  • Accessibility Statement
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom

My Services

  • All New Releases
  • Online Member Center
  • ProfNet

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2022 Cision US Inc.